Drug Adherence Marker
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker (NCT05918341) | The Netherlands Cancer Institute | 2023-07-03 |
Track Drug Adherence Marker automatically
Every clearance here is in the API, with alerts when new ones post.